Passage Bio, Inc.
PASG
$0.3117
-$0.0145-4.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.71M | 7.25M | 6.51M | 6.52M | 6.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.27M | 15.91M | 16.94M | 18.05M | 18.45M |
| Operating Income | -14.27M | -15.91M | -16.94M | -18.05M | -18.45M |
| Income Before Tax | -12.73M | -19.34M | -15.99M | -16.71M | -16.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.73M | -19.34M | -15.99M | -16.71M | -16.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.73M | -19.34M | -15.99M | -16.71M | -16.76M |
| EBIT | -14.27M | -15.91M | -16.94M | -18.05M | -18.45M |
| EBITDA | -13.55M | -15.15M | -16.14M | -17.24M | -17.64M |
| EPS Basic | -0.21 | -0.31 | -0.26 | -0.30 | -0.31 |
| Normalized Basic EPS | -0.13 | -0.15 | -0.16 | -0.19 | -0.19 |
| EPS Diluted | -0.21 | -0.31 | -0.26 | -0.30 | -0.31 |
| Normalized Diluted EPS | -0.13 | -0.15 | -0.16 | -0.19 | -0.19 |
| Average Basic Shares Outstanding | 61.86M | 61.76M | 61.68M | 56.30M | 54.88M |
| Average Diluted Shares Outstanding | 61.86M | 61.76M | 61.68M | 56.30M | 54.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |